arBtrage CAPITALIZING MARKETS checking… Sign in

Precigen, Inc.

PGEN Health Care Biotechnology: Pharmaceutical Preparations
$3.58
▼ -7.2% Today
as of Jun 7, 07:24 ET
Last 30 days -10.95% Apr 28 → Jun 05
$3.50 $3.79 $4.09 $4.39 $4.68 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$3.84
High
$3.88
Low
$3.53
Volume
$5M
Avg Vol
$5M
Mkt Cap
$1.6B
P/E (TTM)
Beta
52w High
$5.47
52w Low
$1.30
Div Yield
Shares Out
$356M

Overview

52-week range
$1.30
$5.47
55% of range
Avg surprise (last 2)
+22.9%
Avg reaction (last 2)
-1.7%
50% positive
Latest IV / EM
50%
EM ±7.0% · $4 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.06$-0.80$-0.54$-0.28$-0.02 Actual $-0.08Actual $-0.08Actual $-0.10Actual $-0.23Actual $-0.09Actual $-0.07Est $-0.08Actual $-0.09Actual $-1.06Actual $-0.02Est $-0.03 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-146M$-112M$-77M$-43M$-8M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.02 $-0.03 +33.3% +71.4% +1.7% earnings
Tue Sep 30, 2025Sep 2025 $-1.06 financials
Mon Jun 30, 2025Jun 2025 $-0.09 financials
Wed May 14, 2025Mar/2025 $-0.07 $-0.08 +12.5% -5.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.09 financials
Sun Jun 30, 2024Jun 2024 $-0.23 financials
Sun Mar 31, 2024Mar 2024 $-0.10 financials
Sat Sep 30, 2023Sep 2023 $-0.08 financials
Fri Jun 30, 2023Jun 2023 $-0.08 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-6M$-23M
Net income$-8M$-146M$-27M$-54M$-24M$-59M
EPS (diluted)$-0.02$-1.06$-0.09$-0.18$-0.09$-0.23

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$7M$30M$14M$14M$6M$30M$25M$9M
Inventory
Total current assets$102M$115M$130M$63M$85M$102M$35M$24M
Total assets$139M$156M$171M$102M$129M$145M$83M$73M
Long-term debt$94M$93M
Total liabilities$118M$135M$129M$108M$113M$79M$28M$30M
Total equity$20M$21M$42M$-37M$-14M$39M$55M$43M

Implied volatility — last 90 days

45%47%50%52%55% Jun 07 — IV 50% · EM ±7.0%

Sector peers